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SummAry – little is known about gender-associated differences in characteristics and sur-
vival of acute heart failure patients. The increasing incidence calls for investigating the possibilities 
of improved management. The purpose of the study was to determine gender-associated differences 
among emergency department acute heart failure patients in order to improve treatment quality 
and survival. A prospective observational study on 22,713 patients was conducted at the university 
Hospital Center emergency department during 2010 and included 726 consecutive acute heart fai-
lure patients. The most common cause of acute heart failure was worsening of chronic heart failure. 
Females suffered more frequently from hypertensive acute heart failure and males from acute heart 
failure associated with acute coronary syndrome. Females were older, with higher body mass in-
dex, atrial fibrillation, urinary tract infections, hypertension history, hypertension at admission, and 
SAPS II score at admission. males had a higher frequency of ST-elevation myocardial infarction 
and dilated cardiomyopathy, confirmed by ultrasound as lower ejection fraction and left ventricle di-
latation with reduced ejection fraction. males were more frequently smokers with a history of chro-
nic obstructive pulmonary disease. The importance of treating hypertension and atrial fibrillation in 
women and acute coronary syndrome and chronic obstructive pulmonary disease in men should be 
emphasized. Aggressive identification and management of all possible heart failure etiologies should 
be recommended in the emergency department.
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Introduction
little is known about gender-associated differences 
in baseline characteristics and survival in acute heart 
failure patients. The increasing incidence of heart fail-
ure patients calls for investigating the possibilities of 
their improved management. The aim of the present 
study was to investigate acute heart failure gender-
associated differences that might be used to improve 
patient treatment, quality of life and survival. 
The european Society of Cardiology (eSC) guide-
lines 2008 for the diagnosis and treatment of acute 
heart failure and chronic heart failure define acute 
heart failure as a rapid onset or change in the signs 
and symptoms of heart failure resulting in the need 
of urgent therapy. Acute heart failure may be either 
new heart failure or worsening of preexisting chronic 
heart failure1. The combination of aging population, 
improved acute myocardial infarction (AmI) sur-
vival, and better prevention of sudden cardiac death 
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has entailed rapid growth in the number of patients 
currently living with chronic heart failure. In addi-
tion, hospitalization for acute heart failure poses a 
major and growing health care burden2. According 
to the World Health Organization (WHO), car-
diovascular diseases were the cause of 17.3 million 
deaths worldwide in 2008, and it is estimated that 
by 2030, almost 23.6 million people will die from 
cardiovascular diseases3. Heart failure is a significant 
and growing problem in europe with a prevalence of 
0.4%-2%, and it is a major and growing cause of in-
hospital mortality in developed countries4,5. Accord-
ing to the national database, heart failure was the 
third most common cause of death among women 
and fourth among men in 20096. Patients suffer-
ing from acute heart failure frequently present to 
emergency department (ed) requiring a demanding 
management. 
Since there are still gaps in evidence, the eSC 
considers there is a need of further evaluation of treat-
ments in females and the elderly because they have 
not been adequately represented in clinical research-
es1. According to some findings, there is no gender-
associated difference in patient survival, and therefore 
there are still no recommendations for gender-associ-
ated management of acute heart failure patients. We 
postulate that identification and proper treatment of 
gender-associated concomitant diseases can improve 
the quality of life and survival of acute heart failure 
patients.
Patients and Methods 
Study design and setting
This prospective observational study was de-
signed to assess the gender-associated baseline char-
acteristics, management, and survival in acute heart 
failure patients treated in ed. The investigation was 
performed in line with the principles outlined in the 
declaration of Helsinki 1975, as revised in 2008, 
and was approved by the ethics Committees of the 
Sestre milosrdnice university Hospital Center and 
School of medicine, university of Zagreb. The study 
was conducted at emergency department of the 
Sestre milosrdnice uHC (uHC ed) with a 50-km 
catchment area and 350,000 catchment population. 
Selection of study patients
All patients that presented to ed with the symp-
toms of acute heart failure in 2010 were included in 
the study, divided into two groups by gender. Acute 
shortness of breath was the primary complaint. Heart 
failure was diagnosed according to eSC guidelines 
2008 and by the uHC workup1. Patient eligibility was 
determined by the attending ed physician. The pa-
tients were additionally divided into six clinical groups 
according to the eSC guidelines 2008 for the diag-
nosis and treatment of acute heart failure, as follows: 
1) worsening or decompensated chronic heart failure; 
2) pulmonary edema; 3) hypertensive heart failure; 4) 
cardiogenic shock; 5) isolated right heart failure; and 
6) acute coronary syndrome and heart failure1. Patient 
management was based on the uHC ed protocols 
and in accordance with international guidelines.
Interventions
Patient identity was protected by database coding. 
Patients with a false-positive diagnosis were excluded 
from the study (Fig. 1). The exclusion criteria were age 
under eighteen, severe renal failure (serum creatinine 
>400 μmol/l), and patients requiring early transfer to 
another hospital. Patients that developed heart failure 
secondary to admission for another illness or after an 
interventional procedure were not included. Screen-
ing of consecutive patients provided some protection 
from systematic error. 
Data collection, processing, and measurements
On admission, all patients underwent initial rou-
tine clinical assessment that included history, physical 
examination, electrocardiography (eCG), ed blood 
tests including arterial blood gas analysis, chest x-ray, 
and heart ultrasound as standard uHC diagnostic 
and treatment protocols. The abstractors prospectively 
collected data in an online database from the hospi-
tal ed electronic chart. data were collected by the 
standard written protocol and monitored by a senior 
physician. Practice runs and regular meetings were 
performed to check performance of abstractors. Im-
portance of missing data was discussed with a senior 
physician-monitor. eCG and imaging chest x-ray, 
echocardiography (n=147) (Sequoia Acuson, Ocean-
side, HCA, uSA), ejection fraction (eF) measured 
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according to Simpson method were done as standard 
uHC diagnostic and treatment protocols. Body mass 
index (BmI) was calculated according to Quetelet’s 
formula as the ratio of body weight to body height 
square (kg/m2). Waist circumference was measured 
with a flexible tape placed on a horizontal plane at 
the level of iliac crest. Blood pressure (BP) was mea-
sured with a mercury sphygmomanometer (riester, 
Jungingen, Germany) under standardized conditions 
in supine position. Hypertension was diagnosed ac-
cording to the WHO criteria (BP ≥140/90 mm Hg 
or current antihypertensive treatment). diabetes was 
diagnosed in patients with dietary treatment, antidi-
abetics, or current fasting plasma glucose levels higher 
than 7.0 mmol/l. Hyperlipidemia was defined as the 
low-density lipoprotein (ldl) cholesterol level >3.5 
mmol/l, or if the patient was taking a lipid-lowering 
drug. According to cigarette smoking, patients were 
classified as current smokers (smoking more than 
five cigarettes/day within the past 3 months), former 
smokers (>3 months and <10 years) or non-smokers. 
Blood samples for laboratory assays were obtained at 
ed admission. Blood samples in ethylenediaminetet-
raacetic acid (edTA)-K3 containing tubes were used 
for hematologic assays (Coulter-Counter S plus junior, 
Coulter electronics ltd., luton, uK). Coagulation 
parameters were assessed from blood samples taken in 
3.8% sodium citrate containers and analyzed (dade 
Behring, marburg, Germany). Serum creatinine, 
bilirubin, aspartate transaminase, alanine transami-
nase, blood glucose level, total plasma cholesterol, 
triglycerides, ldl, and high-density lipoprotein 
(Hdl) cholesterol were measured on the automated 
multi-channel selective analyzers Olympus Au2700 
and Olympus Fractoscan junior (Olympus diagnos-
tica GmbH, Hamburg, Germany). High sensitivity 
C-reactive protein (hsCrP) concentration was mea-
sured on the automated multichannel selective ana-
lyzer modular (roche diagnostics, mannheim, Ger-
many) according to the manufacturer’s instructions. 
Acute Physiology and Chronic Health evaluation II 
score (APACHe II), new york Heart Association 
(nyHA) Functional Classification, and Simplified 
Acute Physiology Score II (SAPS II) were calculated 
with online calculators7-9. The final discharge diagno-
sis of acute heart failure made by attending physician 
was based on all the information available, including 
response to therapy and autopsy data in patients that 
died in the hospital.
Outcome measures
The main outcome measure was survival. Second-
ary outcome measures were types of acute heart fail-
ure according to the eSC Guidelines 20081. Good 
outcome was defined as discharge from the ed or 
hospital.
All ED pts (Jan 1 – Dec 31, 2010)
n=22,713
AHF pts at ED admission 
n=1526
All ED pts (Jan 1 – Jun 30, 2010)
n=11,555




Pts not meeting criteria for AHF 
n=151
Pts excluded from study:
Age under eighteen n=1
Serum creatinine >400 µmol/L n=9






Fig. 1. Flow diagram of Emergency Department acute heart failure patients 
included in the survey.
AHF = acute heart failure; ed = emergency department; pts = patients
260 Acta Clin Croat,  Vol. 54,   No. 3,  2015
Ines Potočnjak et al. Gender related differences in acute heart failure patients
Primary data analysis
Complete data analysis was done in 726 consecu-
tive patients examined in the ed during the first six 
months in 2010. All statistical analyses were per-
formed with the Statistical Package for the Social Sci-
ences (SPSS) version 17.0 for Windows (SPSS, Chica-
go, Il, united States). The χ2-test and Student’s t-test 
were used as appropriate. Continuous data (patient 
age, BmI, eF) were presented as mean ± standard de-
viation (Sd). Proportions were expressed as percent-
age and 95% confidence interval (95% CI). A p-value 
of 0.05 was considered statistically significant.
Data presentation
data were presented in tables as groups of charac-
teristics and variables of acute heart failure patients by 
gender. Characteristics and variables were organized 
in five groups, as follows: 1) baseline characteristics; 2) 
underlying and/or concomitant diseases; 3) symptoms 
and signs; 4) echocardiographic and eCG findings; 
and 5) medication before admission, on admission, 
and at discharge.
Results
Characteristics of study patients
In 2010, a total of 22,713 ed patients were 
screened, 11,555 of them recorded in the first six 
months. There was a total of 1526 (6.7%) patients with 
suspected or confirmed acute heart failure, 894 (7.7%) 
of them diagnosed in the first six months. Following 
exclusion of patients with a false-positive diagnosis 
(n=151) and engagement of exclusion criteria (n=17), 
complete statistical analysis was done on 726 patients, 
409 (56.3%) of them women. Patients were admitted 
from home or nursing home (n=646; 89.7%), another 
department (n=28; 3.9%), or another hospital (n=46; 
6.4%). The mean patient age was 75.7±9.7 years; wom-
en were on average five years older than men, with a 
mean age of 78.2±9.4 years (p<0.001; 95% CI 3.63-
6.47). The mean BmI of study patients was 27.9 kg/
m2, which classified them as overweight. Females had 
by 2.6 kg/m2 higher BmI (29.2±6.7 kg/m2; p=0.032; 
95% CI 0.22-4.9). Almost half (n=297; 40.9%) of the 
patients required hospital admission and treatment, 
Table 1. Gender-associated differences in patient baseline characteristics and clinical presentation of acute heart failure1
Characteristic Female, n (%) male, n (%) n (%)
no. of patients 409 (56.3) 317 (43.7) 726 (100)
no. of hospitalizations 159 (53.5) 138 (46.5) 297 (40.9)
AHF readmission within six months 141 (58.0) 102 (42.0) 243 (33.4)
mean ± Sd mean ± Sd mean ± Sd
*Age (years)§ 78.2±9.4 73.1±9.9 75.7±9.7
*BmI (kg/m2)†† 29.2±6.7 26.6±5.1 27.9±5.9
Clinical presentation of AHF n (%) n (%) n (%)
Worsening or decompensation of CHF 195 (54.8) 161 (45.2) 356 (49.5)
Hypertensive HF† 108 (63.5)   62 (36.5) 170 (23.6)
Isolated right HF   51 (60.0)   34 (40.0)   85 (11.8)
Pulmonary edema   27 (50.0)   27 (50.0)   54 (7.5)
Cardiogenic shock   14 (51.9)   13 (48.1)   27 (3.8)
ACS and HF†     9 (33.3)   18 (66.7)   27 (3.8)
AHF = acute heart failure; CHF = chronic heart failure; HF = heart failure; BmI = body mass index; ACS = acute coronary syndrome; 
Sd = standard deviation; categorical variables are expressed as numbers and percentages; p-values: Pearson χ2-test with yates correction; 
*independent t-test; §p<0.001; †p=0.046; ††p=0.032
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and one-third of them (n=243; 33.5%) had readmis-
sion for acute heart failure within the next six months 
(Table 1). Out of 726 patients, 398 (55%) had symp-
toms of acute heart failure for three or more days prior 
to admission to the ed. The mean length of hospital 
stay was 9.3 days, 1.3 days at the Intensive Care unit 
and 8.3 days at the department of medicine. The 
overall mortality rate was 9.2% (n=67); autopsy was 
performed in 10.4% of non-survivors. There was no 
gender-associated difference in survival. 
Main results
The patients were allocated into six groups ac-
cording to the recently published eSC guidelines for 
the diagnosis and treatment of acute heart failure: 1) 
worsening or decompensation of chronic heart fail-
ure (49.5%); 2) hypertensive heart failure (23.6%); 3) 
isolated right heart failure (11.8%); 4) pulmonary ede-
ma (7.5%); 5) cardiogenic shock (3.8%); and 6) acute 
coronary syndrome and heart failure (3.8%) (Table 
1)1. Gender-associated differences were recorded in 
the hypertensive acute heart failure group (26.7% vs. 
19.7%; p=0.046) for females, and in the acute coro-
nary syndrome with heart failure group (2.2% vs. 
5.7%; p=0.046) for males. The survey highlighted the 
fact that most acute heart failure patients had several 
cardiovascular and non-cardiovascular diseases in ad-
dition to heart failure. Females and males significantly 
differed in underlying and concomitant diseases (Table 
2). Symptoms and signs did not differ between gen-
ders. The chief complaint was dyspnea (85.4%) (Table 
3). Females were more frequently adipose (17.4% vs. 
12%; p=0.004) with a higher frequency of hyper-
tension at ed presentation (86% vs. 75%; p<0.001), 
males had a higher frequency of ST-elevation myo-
cardial infarction (STemI) (n=28; 3.8% of both gen-
ders) (18.5% vs. 6.1%; p=0.034). ed heart ultrasound 
(n=147 of both genders) revealed a higher frequency 
of four-chamber dilation (18.3% vs. 6.3%; p=0.022), 
left ventricle dilation (53.5% vs. 23.8%; p<0.001), and 
lower eF (39.1 vs. 45.4 %; p=0.003; 95% CI 2.12-
10.58) in males. According to the nyHA Functional 
Classification, the patients were distributed as fol-
lows: nyHA I 1.8%, nyHA II 45.5%, nyHA III 
42%, and nyHA IV 10.7%8. Females had a higher 
SAPS II score at ed admission (28.5 vs. 26.6 points; 
p=0.001; 95% CI 0.76-3.11); there was no difference 
Table 2. Gender-associated differences in underlying and concomitant diseases in acute heart failure patients
Characteristic Female, n (%)a male, n (%)a n (%)
underlying diseases 409 (56.3) 317 (43.7) 726 (100)
Hypertension§ 352 (86.7) 238 (75.6) 590 (81.8)
Heart valvular disease 175 (43.1) 141 (44.6) 316 (43.8)
Coronary artery disease 124 (30.5) 113 (35.9) 237 (32.9)
dilated cardiomyopathy§   24 (5.9)   49 (15.5)   73 (10.1)
Concomitant diseases
Atrial fibrillation† 194 (53.0) 130 (44.4) 324 (49.2)
diabetes mellitus 138 (34.0)   95 (30.2) 233 (32.3)
Adiposity††   71 (36.6)   38 (22.6) 109 (30.1)
COPd§   86 (21.2) 101 (32.0) 187 (25.9)
Anemia   94 (23.1)   88 (27.8) 182 (25.2)
Hyperlipidemia   76 (18.8)   67 (21.3) 143 (19.9)
Cigarette smoking§   35 (11.5)   71 (27.1) 106 (18.7)
urinary tract infection§§   54 (13.2)   22 (7.0)   76 (10.5)
aPercentage is expressed within gender; COPd = chronic obstructive pulmonary disease; categorical variables are expressed as numbers 
and percentages; p-values: Pearson χ2-test with yates correction §p<0.001; §§p=0.006; †p=0.028; ††p=0.004
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in APACHe II score (11.3 vs. 10.6 points)7,9. The 
overall mortality rate was 9.2% (n=67); autopsy was 
performed in 10.4% of non-survivors. There was no 
gender-associated difference in survival.
Discussion
As a result of acute heart failure being a clinical 
diagnosis based on presenting symptoms and clini-
cal findings, no investigation might be considered 
as the gold standard for diagnosis confirmation1,10,11. 
The origin of heart failure symptoms is not fully un-
derstood. Symptoms and signs are important as they 
alert the observer to the possibility that heart failure 
exists12. Confirmation and refinement of the diagno-
sis is provided by appropriate investigations such as 
patient history, physical examination, eCG, chest x-
ray, echocardiography, and laboratory investigation, 
with blood gases and specific biomarkers1. Heart fail-
ure is typically associated with multiple clinical signs 
and symptoms that can interact, thereby affecting 
the patient’s perception of some or all of these acute 
symptoms12,13.
Baseline characteristics
The euroHeart Failure Survey recorded that half 
of the patients were female, and that a higher propor-
tion of women (51%) compared to men (30%) were 
aged >75 years4. Female predominance recorded in 
our study (56.3%) confirmed an important difference 
from the Framingham study concerning acute heart 
failure, which has suggested that women not only 
develop heart failure less frequently than men, but 
may also benefit from a lower mortality rate when 
they do14. despite the concept that female sex is not 
an independent predictor of long-term acute heart 
failure mortality, our results showed that women 
were five years older than men15. In addition, females 
were more adipose and had a higher BmI. Obesity 
is considered a major risk factor for cardiovascular 
diseases and heart failure. However, several studies 
have suggested that in the medium term, there is a 
paradoxical relationship between obesity and heart 
failure prognosis, whereby the prognosis for over-
weight or obese heart failure patients is better than 
for normal weight patients16. yet, weight loss in se-
Table 3. Gender-associated differences in symptoms and signs of acute heart failure patients on admission to Emergency 
Department
Characteristic Female, n (%)a male, n (%)a n (%)
409 (100) 317 (100) 726 (100)
Symptom
dyspnea 347 (84.8) 273 (86.4) 620 (85.5)
Fatigue 249 (61.2) 193 (61.3) 442 (61.2)
Orthopnea 226 (55.4) 158 (50.0) 384 (53.0)
Cough 123 (30.1) 104 (32.9) 227 (31.3)
Chest pain 101 (24.8)   79 (25.1) 180 (24.9)
Symptom duration >72 hours 235 (57.6) 163 (51.6) 398 (55.0)
Signs 409 (56.3) 317 (43.7) 726 (100)
Systolic blood pressure >150 mm Hg§ 133 (32.8) 65 (20.7) 198 (27.5)
Pulse rate >100/min 129 (32.0) 110 (35.1) 239 (33.4)
respiratory rate >30/min   37 (9.1)   24 (7.6)   61 (8.4)
right pleural effusion§§   60 (14.7)   53 (16.8) 113 (15.6)
Bilateral pleural effusion§§   57 (14.0)   60 (19.0) 117 (16.2)
dilated neck veins 127 (31.4) 110 (34.9) 237 (32.9)
Hepatomegaly† 105 (26.0) 116 (36.9) 221 (30.8)
aPercentage is expressed within gender; categorical variables are expressed as numbers and percentages; p-values: Pearson χ2-test with 
yates correction §p<0.001; §§p=0.019; †p=0.002
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verely overweight persons and smoking cessation can 
reduce the risk1,17. Previous studies have reported that 
elderly patients that survive hospitalization for heart 
failure are particularly vulnerable to readmission18. 
The striking rate of readmission demands effort to 
develop preventive strategies for this outcome. Fail-
ure in hospital bed utilization could be responsible 
for a substantial proportion of short-term acute heart 
failure readmissions. Although compliance with 
medication treatment and lifestyle changes such as 
salt intake restriction is recommended, it is unclear 
whether this information was provided to the pa-
tients19. According to published reports, in-hospital 
mortality was approximately 20% and many patients 
with heart failure died or were re-hospitalized with-
in the next six months19. Compared to these studies, 
our data suggest that the quality of care and survival 
of acute heart failure patients has improved in the 
last decade; the recorded mortality rate was 9.6% 
and was expected when adjusted to APACHe II 
and SAPS II points (expected mortality 10-14 points 
15% and 29 points 9.7%). male gender emerged as a 
prognostic risk factor only after correction for age20.
Underlying and concomitant diseases
The main findings in this study were that females 
more frequently had hypertension and hypertensive 
acute heart failure, while males were more frequently 
cigarette smokers, suffered from chronic obstructive 
pulmonary disease (COPd), and had definitive di-
agnosis of acute heart failure associated with acute 
coronary syndrome. Hypertension, coronary artery 
disease, and valvular dysfunction were most fre-
quently the causal risk factors for acute heart failure 
or co-existed with another primary etiology in the 
study, as reported elsewhere1,11,21. diabetes mellitus 
as a risk factor was frequently a concomitant disorder 
in acute heart failure patients; however, there was no 
significant gender-associated difference1. An acute 
heart failure patient requires immediate diagnostic 
evaluation and care, and frequent resuscitative mea-
sures to improve symptoms and survival22. COPd 
patients have a markedly elevated risk of heart fail-
ure, and COPd is a strong and independent risk 
factor for cardiovascular morbidity and mortality23. 
Coronary artery disease is a major contributor to the 
development of chronic heart failure, particularly in 
men24.
Symptoms and signs
Acute heart failure symptoms and signs did not dif-
fer between genders. The main complaint of dyspnea 
(85.5%) was the most disturbing symptom the patients 
experienced and often urged them to seek medical 
care25. It requires urgent attention upon presentation. 
Surprisingly, there was a lack in the use of oxygen in 
the ed acute heart failure patients (41.6%), although 
it is part of every acute heart failure management 
algorithm1,12. noninvasive ventilation relieves dyspnea 
in acute heart failure and its use has been associated 
with decreased resource utilization and mortality26.
Echocardiographic and electrocardiographic findings
Several diagnostic tests are routinely employed to 
confirm or rule out the diagnosis of heart failure. An 
eCG should be performed in every patient with sus-
pected heart failure1. doppler echocardiography is an 
essential diagnostic tool for the evaluation of the func-
tional and structural changes underlying or associated 
with acute heart failure. The prevalence of heart failure 
rises as a function of its severity, but it is also known that 
persistent atrial fibrillation with an uncontrolled ven-
tricular response may induce heart failure27. echocar-
diography, the most useful method for evaluating sys-
tolic and diastolic dysfunction, is the preferred method 
for documenting cardiac dysfunction at rest1,12.
Medication before admission, on admission, and at 
discharge
Cardiac glycosides, an old-fashioned heart failure 
medication that may continue having a role in patients 
with atrial fibrillation, was used in about one-third of 
the study population, significantly more in females, 
where atrial fibrillation was more frequent28. According 
to the euroHeart Failure Survey, the prescription of 
cardiac glycosides has significantly increased in patients 
with supraventricular tachycardia/atrial fibrillation28. 
digoxin improves the hemodynamics in heart failure 
without activating neurohormones or negatively affect-
ing the heart rate, blood pressure, or renal function29. 
due to higher blood pressure at ed admission, females 
were more frequently treated with nitrates as acute 
264 Acta Clin Croat,  Vol. 54,   No. 3,  2015
Ines Potočnjak et al. Gender related differences in acute heart failure patients
therapy, while males had more nitrates at discharge for 
the treatment of concomitant coronary artery disease2. 
It can also be useful to relieve dyspnea12. despite simi-
lar treatment regimens at discharge, significantly more 
males were discharged with amiodarone, an observa-
tion also supported by other studies15. Only a limited 
number of ed acute heart failure patients have an 
absolute indication for cardiac monitoring and a high 
level of care, which is very important in the settings of 
restricted ed resources. An acute heart failure patient 
may recover extremely well, depending on the etiology 
and underlying pathophysiology. Prolonged ward treat-
ment and expert care are required in one-half of the pa-
tients. A multidisciplinary approach appears to provide 
an important opportunity to improve the outcomes of 
these patients.
Limitations
By its observational design, this study could only 
partly elucidate the causes of the results and explain 
the gender-associated differences in acute heart fail-
ure patients. The use of a convenience sample was the 
limitation, but unlikely to have introduced systematic 
bias. The screening of consecutive patients provided 
some protection from systematic error. measurement 
of the heart failure biomarker brain natriuretic peptide 
was available for a small proportion of the patients, so 
they were not included in the survey.
Conclusion
Our research showed patient gender to be clini-
cally relevant for the presentation of acute heart fail-
ure. However, gender is not an independent predictor 
of mortality. According to the present study results, 
early identification and proper treatment of gender-
associated concomitant diseases, e.g., hypertension 
and atrial fibrillation in females, and acute coronary 
syndrome and COPd in males, could improve acute 
heart failure patient quality of life and survival. To 
conclude, aggressive identification and management 
of all possible etiologies of heart failure should be rec-
ommended in the ed.
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Sažetak
rAZlIKe PremA SPOlu u BOleSnIKA S AKuTnIm ZATAJIVAnJem SrCA PrImlJenIH nA HITnI 
PrIJAm
I. Potočnjak, T. Bodrožić-Džakić, I. Šmit, M. Trbušić, M. Milošević i V. Degoricija
malo toga je poznato o spolno-zavisnim razlikama u značajkama i preživljenju bolesnika s akutnim zatajivanjem srca. 
rastuća incidencija obvezuje na ispitivanje mogućnosti poboljšanog liječenja. Svrha ove studije je bila utvrditi spolno-zavi-
sne razlike u bolesnika s akutnim zatajivanjem srca u hitnom prijmu radi poboljšanja kvalitete liječenja i preživljenja. Pros-
pektivna opservacijska studija na 22.713 bolesnika je provedena u hitnom prijmu Sveučilišnog bolničkog centra tijekom 
2010. godine i uključila je 726 uzastopnih bolesnika s akutnim zatajivanjem srca. najučestaliji uzrok akutnog zatajivanja 
srca bilo je pogoršanje kroničnog zatajivanja srca. Žene su učestalije bolovale od hipertenzivnog akutnog zatajivanja srca, a 
muškarci od akutnog zatajivanja srca udruženog s akutnim koronarnim sindromom. Žene su bile starije, s višim indeksom 
tjelesne mase, atrijskom fibrilacijom, infekcijama mokraćnog sustava, anamnezom hipertenzije, hipertenzijom kod prijma 
i višim zbirom SAPS II. pri prijmu. muškarci su imali višu učestalost srčanog infarkta s ST-elevacijom i dilatacijske kardi-
omiopatije, ultrazvučno potvrđenu sniženom izbačajnom frakcijom i dilatacijom lijeve klijetke sa smanjenom izbačajnom 
frakcijom. muškarci su učestalije bili pušači s anamnezom kronične opstruktivne bolesti pluća. Treba naglasiti važnost 
liječenja hipertenzije i atrijske fibrilacije u žena te akutnog koronarnog sindroma i kronične opstruktivne bolesti pluća u 
muškaraca. Agresivnu identifikaciju i liječenje svih mogućih etiologija zatajivanja srca treba preporučiti u hitnom prijmu.
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